Laurus Labs informs about board meeting

Laurus Labs Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 540222 | NSE: LAURUSLABS

20 Oct 2021 Evaluate

Laurus Labs has informed that the meeting of the Board of Directors of the Company is scheduled on 28/10/2021 to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021; to consider the proposal for payment of Interim Dividend for FY 2021-22 and fixation of record date for determining the eligibility of shareholders (if approved).

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1853.00
Dr. Reddys Labs.	1200.40
Cipla	1404.00
Lupin	2098.00
Zydus Lifesciences	1180.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.